COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 938: Articles 9371-9380  | Next

The MU Study of Seropositivity and Risk for SARS-CoV-2 and COVID-19: Crucial Behavioral and Immunological Data from Midwestern College Students
Myroniuk, T. W., Hermsen, J. M., Hamilton, C., David, I., Teti, M., Ranjit, Y. S., Woodrey, S. N., Stilley, J. A. W., Teixeiro, E., Guan, Y., Daniels, M., Schatz, E.
10.1101/2022.01.24.22269758 — Posted: 2022-01-25
mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
Girard, B., Tomassini, J., Deng, W., Maglinao, M., Zhou, H., Figueroa, A., Gamloush, S. S., Montefiori, D. C., Das, R., Pajon, R.
10.1101/2022.01.24.22269666 — Posted: 2022-01-25
Establishment of human post-vaccination SARS-CoV-2 standard reference sera
Xiang, J., Katz, L., Winokur, P. L., Chaudhary, A., Bradford, R., Rashid, S., Ghosh, S., Robertson, A., Menetski, J., Lee, T., Poelaert, B., Eastman, R. T., Hall, M. D., Stapleton, J. T.
10.1101/2022.01.24.22269773 — Posted: 2022-01-25
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time
Gentles, L. E., Kehoe, L., Crawford, K. H., Lacombe, K., Dickerson, J., Wolf, C., Yuan, J., Schuler, S., Watson, J. T., Nyanseor, S., Briggs-Hagen, M., Saydah, S., Midgley, C. M., Pringle, K., Chu, H. Y., Bloom, J. D., Englund, J. E.
10.1101/2022.01.14.22269235 — Posted: 2022-01-25
Lung Perfusion Disturbances Detected with MRI in Non-Hospitalized Post-COVID-19 Individuals with Dyspnea 3 -13 Months after the Acute Disease
Yu, J., Granberg, T., Shams, R., Petersson, S., Skold, M., Nyren, S., Lundberg, J.
10.1101/2022.01.25.22269717 — Posted: 2022-01-25
Projection of Healthcare Demand in Germany and Switzerland Urged by Omicron Wave (January-March 2022)
Gorji, H., Stauffer, N., Lunati, I., Caduff, A., Bühler, M., Engel, D., Chung, H. R., Loukas, O., Feig, S., Renz, H.
10.1101/2022.01.24.22269676 — Posted: 2022-01-25
Structural insight into antibody evasion of SARS-CoV-2 omicron variant
Verma, J., Subbarao, N.
10.1101/2022.01.25.477671 — Posted: 2022-01-25
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
Chaguza, C., Coppi, A., Earnest, R., Ferguson, D., Kerantzas, N., Warner, F., Young, H. P., Breban, M. I., Billig, K., Koch, R. T., Pham, K., Kalinich, C. C., Ott, I. M., Fauver, J. R., Hahn, A. M., Tikhonova, I. R., Castaldi, C., Kumar, B. D., Pettker, C. M., Warren, J. L., Weinberger, D. M., Landry, M. L., Peaper, D. R., Schulz, W., Vogels, C. B. F., Grubaugh, N. D.
10.1101/2022.01.22.22269660 — Posted: 2022-01-25 Discussion: Onsite
Binding of Human ACE2 and RBD of Omicron Enhanced by Unique Interaction Patterns Among SARS-CoV-2 Variants of Concern
Kim, S., Liu, Y., Ziarnik, M., Cao, Y., Zhang, X. F., Im, W.
10.1101/2022.01.24.477633 — Posted: 2022-01-25
Structural Ramifications of Spike Protein D614G Mutation in SARS-CoV-2
Dokainish, H. M., Sugita, Y.
10.1101/2022.01.24.477651 — Posted: 2022-01-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).